Webinar | Navigating FDA Compliance: Defining Your QMSR Journey
This webinar has now expired: To Download The Full Presentation Click…
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 127–135 of 689
This webinar has now expired: To Download The Full Presentation Click…
The EMDN MDCG 2025 update has been released, incorporating feedback from the 2024 Public Consultation and the MDCG Nomenclature Working…
As of January 2024, The Climate and Innovation Act (KIG) has officially come into force, setting a clear pathway for…
An update to Australia’s guidance on the use of market authorization evidence from overseas regulators for medical devices, including in-vitro…
On April 3, 2024, the European Commission adopted Regulation (EU) 2024/996, bringing further amendments to the Cosmetics Regulation (No. 1223/2009).
Responsible for approximately 50% of the estimated USD 578.75 billion global medical device market (in 2024), North America continues…
For US medical device manufacturers considering non-US markets, understanding the influence of North America’s dominant medical device landscape and…
MDCG has made minor modifications to the MDCG 2023-3 guidance, “Questions and Answers on vigilance terms and concepts…
The FDA has issued their draft recommendations (January 2025), regarding the content of marketing submissions for medical devices that…
Showing 127–135 of 689